SlideShare ist ein Scribd-Unternehmen logo
1 von 8
Antimycobacterial Drugs –
Used for Treatment of
Tuberculosis

By,
Ishaque P.K
Biochemistry & Molecularbiology
Pondicherry University
Introduction to Mycobacteria
• Aerobic bacilli
• Gram positive – Do not stain well with Gram stain

• Acid fast – Bind phenol based dyes (carbol fuchsin) and resist
acid alcohol decoloration (Ziehl-Neelsen stain).
• Non spore forming
• Non motile, rods with varying sizes (1-10μm)
• Catalase positive
• Many mycobacteria produce pigments on culture
• Relatively simple growth medium required

• Rapid (<7 days) or slow growing (weeks or months)
• Most of them are pathogens, they are slow growing
Mycobacterium species of clinical importance
• Mycobacterium tuberculosis : TB in humans but also cats,
dogs, pigs, chickens, parrots, canaries, guinea pigs and mice
• Mycobacterium bovis : bovine tuberculosis, also TB in man,
other ruminants, pigs and more rarely in horses, dogs, cats.
• Mycobacterium avium subsps.Paratuberculosis : Johne’s
disease in cattle, sheep, goats and deer .
• Mycobacterium avium complex : TB in birds, poultry very
susceptible. Pigs susceptible but not cattle. Sporadic cases in
horses, dogs and cats. Opportunist in man (AIDS – M. avium
intracellulare)
• M. Leprae - Leprosy (man, mice, armadillos)
• M. lepraemurium, M. ulcerans, M. kansasii, M. fortuitum
and M. Chelonae Skin ulceration and lymph node
involvement in many different species, Chronic RTI
Virulence factors of Mycobacteria
• Cell wall components
• Mycolic acids – resist phagocytic digestion.
• Sulfatides – prevent phagocyte activation and phagosomelysosome fusion.
• Trehalose di-mycolate (cord factor) – Inhibits phagocyte
chemotaxis, activation, phagosome-lysosome fusions and
digesion.
• Lipoarabinomannan (LAM) – prevents phagocyte
activation and digestion within the phagocyte.
• Mycosides – prevent intracellular killing and digestion
• Cell wall antigens in general induce DTH
• Other factors include SOD (superoxide dismutase) and
heat shock proteins.
Mycobacterial (acid-fast) cell wall
General Features
• Thick, waxy and complex
• Higher fluidity in more external
regions than internal regions
• Relatively
impermeable
to
hydrophilic solutes
• Contain porins (selective cationic
channels)
Main Components
• Peptidoglycan - contains Nglycolylmuramic acid instead of
N-acetylmuramic acid
• Arabinogalactan
• Mycolic Acids (60% of cellular
envelope)
• Lipoarabinomannan (LAM)
Diagnosis of Mycobacterial infection
• Immunological detection
• ‘tuberculin’ testing- using PPD (purified protein
derivative) from the relevant bacterial species.
• Gama interferon assay
• Laboratory Diagnosis - Microscopy (e.g. Ziehl
Neelsen staining, rhodamine/auramine fluorescent
stain) of appropriate specimens from site of
infection
• Culture – of lymph node, tissue
lesions, sputum, aspirates, milk
• Decontamination of specimens with sodium
hydrochloride, sodium triphosphate, oxalic acid
• Lowenstein Jensen medium (slants) incubated for
up to 8 weeks
• Genomic detection (e.g. PCR)
Antitubercular Drugs

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Antifungal chemotherapy
Antifungal chemotherapyAntifungal chemotherapy
Antifungal chemotherapy
 
Anti mycobacterial drugs
Anti mycobacterial drugsAnti mycobacterial drugs
Anti mycobacterial drugs
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugs
 
Tuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugsTuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugs
 
Antitubercular drugs.
Antitubercular drugs.Antitubercular drugs.
Antitubercular drugs.
 
Antibiotic Therapy
Antibiotic TherapyAntibiotic Therapy
Antibiotic Therapy
 
Antitubercular Drug
Antitubercular Drug Antitubercular Drug
Antitubercular Drug
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugs
 
Antileprotic drugs
Antileprotic drugsAntileprotic drugs
Antileprotic drugs
 
Pharmacology of Anti- Tubercular Drugs
Pharmacology of Anti- Tubercular DrugsPharmacology of Anti- Tubercular Drugs
Pharmacology of Anti- Tubercular Drugs
 
Antifungal antibiotics
Antifungal antibioticsAntifungal antibiotics
Antifungal antibiotics
 
Anti mycobacterial drugs
Anti mycobacterial drugsAnti mycobacterial drugs
Anti mycobacterial drugs
 
Chemotherapy 3 antifungal agents
Chemotherapy 3 antifungal agentsChemotherapy 3 antifungal agents
Chemotherapy 3 antifungal agents
 
Streptomycin
StreptomycinStreptomycin
Streptomycin
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agents
 
16. antifungal
16. antifungal16. antifungal
16. antifungal
 
Antifungal drugs-Antibiotics
Antifungal drugs-AntibioticsAntifungal drugs-Antibiotics
Antifungal drugs-Antibiotics
 
Antiprotozoal for MBBS 2021
Antiprotozoal for MBBS 2021Antiprotozoal for MBBS 2021
Antiprotozoal for MBBS 2021
 
Fluoroquinolones
Fluoroquinolones Fluoroquinolones
Fluoroquinolones
 
Anti-Mycobacterial drugs
Anti-Mycobacterial drugsAnti-Mycobacterial drugs
Anti-Mycobacterial drugs
 

Ähnlich wie Antitubercular Drugs

Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01
Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01
Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01
Tamil D
 
Innate immunity nonspecific defenses of the host-final
Innate immunity nonspecific defenses of the host-finalInnate immunity nonspecific defenses of the host-final
Innate immunity nonspecific defenses of the host-final
Merlyn Denesia
 

Ähnlich wie Antitubercular Drugs (20)

Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01
Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01
Innateimmunity nonspecificdefensesofthehost-final-150330233237-conversion-gate01
 
Innate immunity nonspecific defenses of the host-final
Innate immunity nonspecific defenses of the host-finalInnate immunity nonspecific defenses of the host-final
Innate immunity nonspecific defenses of the host-final
 
Antibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionAntibiotic Mechanisms of Action
Antibiotic Mechanisms of Action
 
Basics of Mycobacterium spp for student.pptx
Basics of Mycobacterium spp for student.pptxBasics of Mycobacterium spp for student.pptx
Basics of Mycobacterium spp for student.pptx
 
9.Microorganisms.pdf
9.Microorganisms.pdf9.Microorganisms.pdf
9.Microorganisms.pdf
 
Mycobacteria
MycobacteriaMycobacteria
Mycobacteria
 
Staph.i lect.
Staph.i lect.Staph.i lect.
Staph.i lect.
 
Endo microbiology -key to success in endo
Endo microbiology -key to success in endoEndo microbiology -key to success in endo
Endo microbiology -key to success in endo
 
Monera
MoneraMonera
Monera
 
umesh ppt.pptx
umesh ppt.pptxumesh ppt.pptx
umesh ppt.pptx
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
Staphylococcus.pptx
Staphylococcus.pptxStaphylococcus.pptx
Staphylococcus.pptx
 
Kingdom Monera
Kingdom MoneraKingdom Monera
Kingdom Monera
 
The changing face of canine pyoderma- new strategies for control
The changing face of canine pyoderma- new strategies for controlThe changing face of canine pyoderma- new strategies for control
The changing face of canine pyoderma- new strategies for control
 
Antimicrobia agents dr. Mahadi
Antimicrobia agents dr. MahadiAntimicrobia agents dr. Mahadi
Antimicrobia agents dr. Mahadi
 
Pyoderma at Vets South, Exeter
Pyoderma at Vets South, ExeterPyoderma at Vets South, Exeter
Pyoderma at Vets South, Exeter
 
Aerobic Non-Spore-Forming Gram-Positive Bacilli
Aerobic Non-Spore-Forming Gram-Positive BacilliAerobic Non-Spore-Forming Gram-Positive Bacilli
Aerobic Non-Spore-Forming Gram-Positive Bacilli
 
M. tuberculosis ppt lecture
M. tuberculosis ppt lectureM. tuberculosis ppt lecture
M. tuberculosis ppt lecture
 
Staphylococcus
Staphylococcus Staphylococcus
Staphylococcus
 

Mehr von IshaqueAbdulla

Mehr von IshaqueAbdulla (9)

Transcription Regulation
Transcription Regulation Transcription Regulation
Transcription Regulation
 
LDH Isoenzymes
LDH Isoenzymes LDH Isoenzymes
LDH Isoenzymes
 
Transcription Regulation in Eukaryotes
Transcription Regulation in EukaryotesTranscription Regulation in Eukaryotes
Transcription Regulation in Eukaryotes
 
Si rna
Si rnaSi rna
Si rna
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
 
Photodynamic therapy
Photodynamic therapyPhotodynamic therapy
Photodynamic therapy
 
Plantibodies
PlantibodiesPlantibodies
Plantibodies
 
Cytokines
CytokinesCytokines
Cytokines
 
Photodynamic Therapy (PDT)
Photodynamic Therapy (PDT)Photodynamic Therapy (PDT)
Photodynamic Therapy (PDT)
 

Kürzlich hochgeladen

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Kürzlich hochgeladen (20)

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 

Antitubercular Drugs

  • 1. Antimycobacterial Drugs – Used for Treatment of Tuberculosis By, Ishaque P.K Biochemistry & Molecularbiology Pondicherry University
  • 2. Introduction to Mycobacteria • Aerobic bacilli • Gram positive – Do not stain well with Gram stain • Acid fast – Bind phenol based dyes (carbol fuchsin) and resist acid alcohol decoloration (Ziehl-Neelsen stain). • Non spore forming • Non motile, rods with varying sizes (1-10μm) • Catalase positive • Many mycobacteria produce pigments on culture • Relatively simple growth medium required • Rapid (<7 days) or slow growing (weeks or months) • Most of them are pathogens, they are slow growing
  • 3.
  • 4. Mycobacterium species of clinical importance • Mycobacterium tuberculosis : TB in humans but also cats, dogs, pigs, chickens, parrots, canaries, guinea pigs and mice • Mycobacterium bovis : bovine tuberculosis, also TB in man, other ruminants, pigs and more rarely in horses, dogs, cats. • Mycobacterium avium subsps.Paratuberculosis : Johne’s disease in cattle, sheep, goats and deer . • Mycobacterium avium complex : TB in birds, poultry very susceptible. Pigs susceptible but not cattle. Sporadic cases in horses, dogs and cats. Opportunist in man (AIDS – M. avium intracellulare) • M. Leprae - Leprosy (man, mice, armadillos) • M. lepraemurium, M. ulcerans, M. kansasii, M. fortuitum and M. Chelonae Skin ulceration and lymph node involvement in many different species, Chronic RTI
  • 5. Virulence factors of Mycobacteria • Cell wall components • Mycolic acids – resist phagocytic digestion. • Sulfatides – prevent phagocyte activation and phagosomelysosome fusion. • Trehalose di-mycolate (cord factor) – Inhibits phagocyte chemotaxis, activation, phagosome-lysosome fusions and digesion. • Lipoarabinomannan (LAM) – prevents phagocyte activation and digestion within the phagocyte. • Mycosides – prevent intracellular killing and digestion • Cell wall antigens in general induce DTH • Other factors include SOD (superoxide dismutase) and heat shock proteins.
  • 6. Mycobacterial (acid-fast) cell wall General Features • Thick, waxy and complex • Higher fluidity in more external regions than internal regions • Relatively impermeable to hydrophilic solutes • Contain porins (selective cationic channels) Main Components • Peptidoglycan - contains Nglycolylmuramic acid instead of N-acetylmuramic acid • Arabinogalactan • Mycolic Acids (60% of cellular envelope) • Lipoarabinomannan (LAM)
  • 7. Diagnosis of Mycobacterial infection • Immunological detection • ‘tuberculin’ testing- using PPD (purified protein derivative) from the relevant bacterial species. • Gama interferon assay • Laboratory Diagnosis - Microscopy (e.g. Ziehl Neelsen staining, rhodamine/auramine fluorescent stain) of appropriate specimens from site of infection • Culture – of lymph node, tissue lesions, sputum, aspirates, milk • Decontamination of specimens with sodium hydrochloride, sodium triphosphate, oxalic acid • Lowenstein Jensen medium (slants) incubated for up to 8 weeks • Genomic detection (e.g. PCR)